Neuroblastoma
📧 Sign up to get email alerts when something new happens for Neuroblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma [Phase 1]
Phase 1 study assessing consolidation with busulfan and melphalan plus autologous stem cell transplant after chemotherapy in newly diagnosed…
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
A completed natural history study followed infants with adrenal masses detected prenatally or neonatally to document disease course for adre…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients [NA]
A completed clinical trial evaluating the effectiveness of the neutropenic diet in pediatric oncology patients, including acute lymphoblasti…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: Combination Chemotherapy Followed by Stem Cell Transplant in High-risk Neuroblastoma Patients [Phase 3]
A Phase 3 trial evaluating combination chemotherapy followed by stem cell transplant in high-risk neuroblastoma has completed enrollment/dat…
-
CLINICAL_TRIALS trial_result · 2016-12-23Clinical Trial Update: Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma [Phase 1]
A Phase 1 study of temsirolimus with valproic acid in children with relapsed neuroblastoma, osteosarcoma, soft tissue sarcoma, or brain tumo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: TPI 287 in Patients With Refractory or Recurrent Neuroblastoma or Medulloblastoma [Phase 1]
Phase 1 trial update reporting results for TPI-287 in patients with refractory or recurrent neuroblastoma or medulloblastoma. The study stat…
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma [Phase 1, Phase 2]
Phase 1/2 safety and efficacy study of TPI-287 in neuroblastoma and medulloblastoma was terminated. Results were posted on 2016-10-28.
-
CLINICAL_TRIALS trial_result · 2016-10-28Clinical Trial Update: Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma [Phase 1, Phase 2]
A randomized Phase 1/2 study evaluating TPI-287 for primary refractory or early relapsed neuroblastoma was terminated. Results were posted i…
-
CLINICAL_TRIALS trial_result · 2016-10-19Clinical Trial Update: Reduced Intensity Stem Cell Transplantation in Children With Relapsed Neuroblastoma After Autologous Transplantation [Phase 2]
A Phase 2 trial evaluating reduced-intensity stem cell transplantation for children with relapsed neuroblastoma after autologous transplanta…
-
CLINICAL_TRIALS trial_result · 2016-10-03Clinical Trial Update: Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma [Phase 3]
Phase 3 trial evaluating cyclophosphamide and prednisone with or without immunoglobulin for abnormal muscle movements in children with neuro…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma [Phase 2]
Phase 2 trial of intensified MIBG therapy with high-dose chemotherapy and autologous stem cell rescue in high-risk neuroblastoma has complet…
-
CLINICAL_TRIALS trial_result · 2016-08-08Clinical Trial Update: Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma [Phase 2]
This is a Phase 2 clinical trial update evaluating a combination of metaiodobenzylguanidine (MIBG) labeled with iodine-131 and topotecan in …
-
CLINICAL_TRIALS trial_result · 2016-08-03Clinical Trial Update: T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies [Phase 1]
Phase 1 study of T cell receptor-transduced T cells targeting NY-ESO-1 in patients with NY-ESO-1-expressing malignancies to assess safety an…
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Molecular Guided Therapy for Refractory or Recurrent Neuroblastoma [NA]
This document reports a completed clinical trial of molecular guided therapy for refractory or recurrent neuroblastoma, with results posted …
-
CLINICAL_TRIALS trial_result · 2016-07-11Clinical Trial Update: Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
This clinical trial update reports on gene mutation analyses in samples from young patients with Pleuropulmonary Blastoma Syndrome at risk f…
-
CLINICAL_TRIALS research · 2016-07-11Clinical Trial Update: Biomarkers in Tumor Samples From Younger Patients With Neuroblastoma
A completed clinical trial update examining biomarkers in tumor samples from younger patients with neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2016-06-24Clinical Trial Update: Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma [Phase 1]
A Phase 1 trial evaluating autologous transplant followed by allogeneic transplant for high-risk Neuroblastoma was terminated.
-
CLINICAL_TRIALS trial_result · 2016-06-21Clinical Trial Update: Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors [Phase 1]
This Phase 1 trial update assesses the safety and feasibility of radiolabeled octreotide in pediatric patients with advanced or refractory s…
-
CLINICAL_TRIALS withdrawal · 2016-06-21Clinical Trial Update: 90Y DOTA/Retinoic Acid for Neuroblastoma and Neuroendocrine Tumor (NET) [Phase 2]
A Phase 2 trial of 90Y DOTA/Retinoic Acid for neuroblastoma and neuroendocrine tumors has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-06-20Clinical Trial Update: Safety Study for Refractory or Relapsed Neuroblastoma With DFMO Alone and in Combination With Etoposide [Phase 1]
Phase 1 safety study of DFMO alone and in combination with etoposide in refractory or relapsed neuroblastoma has completed, with results pos…
-
CLINICAL_TRIALS trial_result · 2016-06-14Clinical Trial Update: Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma [Phase 2]
Phase 2 clinical trial update evaluating anti-angiogenic therapy combined with radiotherapy for pediatric neuroblastoma.
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Response-based Treatment of High-risk Neuroblastoma [Phase 2]
A Phase 2 clinical trial from Samsung Medical Center evaluating response-based treatment for newly diagnosed high-risk neuroblastoma; curren…
-
CLINICAL_TRIALS trial_result · 2016-05-19Clinical Trial Update: Studying Biomarkers in Samples From Patients With High-Risk Neuroblastoma
An update on a completed clinical trial studying biomarkers in samples from patients with high-risk neuroblastoma.
-
CLINICAL_TRIALS research · 2016-05-18Clinical Trial Update: Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma
This clinical trial update reports on biomarker studies using blood and tissue samples from patients with newly diagnosed neuroblastoma. The…
-
CLINICAL_TRIALS trial_result · 2016-05-18Clinical Trial Update: Biomarkers in Young Patients With Neuroblastoma
This ClinicalTrials.gov entry reports that a study on biomarkers in young patients with neuroblastoma has completed.